EU-ATTRACT 2025: International call for research proposals on rare cancer

EU-ATTRACT 2025: International call for research proposals on rare cancer drug development ATTRACT Cancer drug research

ATTRACT is the first international initiative to accelerate drug development for rare cancers by funding cross-border clinical academic research. Building on the success of the first edition, we are excited to announce the launch of a second call for projects in September 2024.

Six European anticancer charities join forces and launch the ATTRACT 2025 call to stimulate international research on the treatment of rare cancers. We invite European researchers and clinicians from different countries to unite and collaborate in setting up late phase (phase 2/3) international clinical trials that aim to advance the development of better drug therapy for rare cancers patients.

Deadline: 11 October 2024 (pre-proposal); End of April 2025 (full proposal)

More information